Medicare billing address
CMS Medicare provider billing file
919 Conestoga RdBldg. One, Suite 300
Bryn Mawr, PA 19010
CMS public data · NPI 1689689473
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Ilia S Zeltser, MD
Specialty
Credential
MD
NPI
1689689473
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Ilia S Zeltser, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
919 Conestoga RdCMS Doctors & Clinicians file
919 Conestoga RdIn the 2024 CMS provider billing file, this NPI had 980 Medicare beneficiaries and 8,381 total services. The average beneficiary age was 75, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$458,887.28
Total Medicare payment amount
$351,751.73
Medicare beneficiaries
980
Total services
8,381
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
73%
CMS beneficiary-panel share
Ischemic heart disease
41%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Diabetes
25%
CMS beneficiary-panel share
Atrial fibrillation
20%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 948 | $138.70 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 935 | $17.65 |
| Manual urinalysis test with examination using microscope, automated | 923 | $3.11 |
| Ultrasound measurement of bladder capacity after voiding | 281 | $12.42 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 267 | $68.04 |
| Insertion of needle into vein for collection of blood sample | 252 | $8.65 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 190 | $178.81 |
| Diagnostic exam of bladder and urethra using an endoscope | 99 | $85.61 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 99 | $52.43 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 72 | $98.27 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1689689473. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Tamsulosin Hcl | Tamsulosin Hcl | 229 | 653.9 | $3,715.90 |
| 2 | Finasteride | Finasteride | 204 | 606.6 | $3,916.40 |
| 3 | Orgovyx | Relugolix | 199 | 199 | $598,643.62 |
| 4 | Alfuzosin Hcl Er | Alfuzosin Hcl | 137 | 371 | $3,101.48 |
| 5 | Xtandi | Enzalutamide | 107 | 115 | $1,432,999.65 |
| 6 | Erleada | Apalutamide | 53 | 53 | $751,037.26 |
| 7 | Tadalafil | Tadalafil | 53 | 108 | $3,215.28 |
| 8 | Gemtesa | Vibegron | 52 | 118 | $54,026.03 |
| 9 | Myrbetriq | Mirabegron | 46 | 130 | $58,132.06 |
| 10 | Methenamine Hippurate | Methenamine Hippurate | 30 | 75.2 | $2,364.59 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2000
Group/practice field
The Centers For Advanced Urology Llp
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.